Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Jan 12, 2007 at 3:42 AM EST

Genentech 4th Quarter Report Kickstarts Biotech Rally

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotech stocks had a great day Thursday as both the Nasdaq (^NBI) and…

Douglas A. McIntyre | Jan 11, 2007 at 4:04 AM EST

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INSMED INC [INSM] +22.33% LEV PHARMACEUTICALS [LEVP.OB] +15.11% ACCENTIA BIOPHARMACE [ABPI] +11.39% NEURALSTEM INC [NRLS.OB] +10.17%…

Douglas A. McIntyre | Jan 11, 2007 at 4:02 AM EST

Cephalon: Rare Biopharmaceutical Value Play for 2007

From BioHealth Investor In December, biopharmaceutical company Cephalon Inc. (CEPH) made the announcement that it has reduced its debt levels…

Douglas A. McIntyre | Jan 11, 2007 at 4:01 AM EST

Genomic Health, Insmed Lead as Biotechs Gain

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Both the Nasdaq (^NBI) and Amex (^BTK) biotech stock indices gained on Wednesday…

Douglas A. McIntyre | Jan 10, 2007 at 4:32 PM EST

Genetech Reacts to Q4 Earnings

Genentech (DNA) traded up marginally after beating expectations. The company posted $0.61 EPS vs $0.56 estimates and total product sales…

Douglas A. McIntyre | Jan 10, 2007 at 4:01 AM EST

Tuesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INNCARDIO INC [ICDO.OB] +180.00% CYTRX CP [CYTR] +15.56% CRITICAL THERAPEUTIC [CRTX] +13.60% INCYTE CORP [INCY] +11.01%…

Douglas A. McIntyre | Jan 10, 2007 at 3:59 AM EST

RNAi developments by Alnylam, CytRx Highlight Tuesday’s Biotech News

by H.S. AyoubBioHealth Investor.com The Nasdaq Biotechnology Index ( ^NBI) gained slightly on Tuesday ending the trading session at $807.34.…

Douglas A. McIntyre | Jan 9, 2007 at 10:25 AM EST

IPO Alert: VeriChip Amended IPO Filing and Backdoor Plays

VeriChip has made an amended filing on its IPO process, and this now looks closer to fruition than it has…

Douglas A. McIntyre | Jan 9, 2007 at 3:19 AM EST

Monday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology POLYMEDIX INC [PYMX.OB] +60.00% SEATTLE GENETICS I [SGEN] +24.01% CYCLACEL PHARMACEUTI [CYCC] +20.93% INNCARDIO INC [ICDO.OB]…

Douglas A. McIntyre | Jan 9, 2007 at 3:16 AM EST

Biotech Indices Mixed as AMEX Gains, Nasdaq Slips

From BioHealth Investor by H.S. AyoubBioHealth Investor.com The major biotech indices were mixed on Monday. The AMEX Biotechnology Index (^BTK)…

Douglas A. McIntyre | Jan 8, 2007 at 6:24 PM EST

Cramer’s Scientific Instrument Purchase for Tomorrow Morning

Tonight Cramer said tonight on his MAD MONEY show on CNBC there is no reason to wait for the J.P.Morgan…

Douglas A. McIntyre | Jan 8, 2007 at 6:10 PM EST

Cramer’s Biotech Pick Ahead of the J.P. Morgan Biotech Conference

Tonight Cramer said tonight on his MAD MONEY show on CNBC there is no reason to wait for the J.P.Morgan…

Douglas A. McIntyre | Jan 8, 2007 at 5:23 PM EST

FDA Fast Tracks Stem Cells for Crohn’s Disease

Osiris Therapeutics (OSIR) was notified that its PROCHYMAL received FDA ‘Fast Track’designation, expediting thedevelopment of the stem cell treatment for…

Douglas A. McIntyre | Jan 8, 2007 at 3:47 AM EST

Friday’s Top Biotech and Medical Stocks

From Biohealth Investor Biotechnology NEURALSTEM INC [NRLS.OB] +9.09% POLYDEX PHARM LTD [POLXF] +8.77% MEMORY PHARMACEUTICA [MEMY] +7.32% STEMCELLS INC [STEM]…

Douglas A. McIntyre | Jan 8, 2007 at 3:45 AM EST

IBD Weekly Top Ranked Medical Stocks

From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative…

1 … 385 386 387 388 389 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Genentech 4th Quarter Report Kickstarts Biotech Rally

Wednesday’s Top Biotech and Medical Stocks

Cephalon: Rare Biopharmaceutical Value Play for 2007

Genomic Health, Insmed Lead as Biotechs Gain

Genetech Reacts to Q4 Earnings

Tuesday’s Top Biotech and Medical Stocks

RNAi developments by Alnylam, CytRx Highlight Tuesday’s Biotech News

IPO Alert: VeriChip Amended IPO Filing and Backdoor Plays

Monday’s Top Biotech and Medical Stocks

Biotech Indices Mixed as AMEX Gains, Nasdaq Slips

Cramer’s Scientific Instrument Purchase for Tomorrow Morning

Cramer’s Biotech Pick Ahead of the J.P. Morgan Biotech Conference

FDA Fast Tracks Stem Cells for Crohn’s Disease

Friday’s Top Biotech and Medical Stocks

IBD Weekly Top Ranked Medical Stocks

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Health and Healthcare Articles

All Health and Healthcare Articles

Genentech 4th Quarter Report Kickstarts Biotech Rally

Wednesday’s Top Biotech and Medical Stocks

Cephalon: Rare Biopharmaceutical Value Play for 2007

Genomic Health, Insmed Lead as Biotechs Gain

Genetech Reacts to Q4 Earnings

Tuesday’s Top Biotech and Medical Stocks

RNAi developments by Alnylam, CytRx Highlight Tuesday’s Biotech News

IPO Alert: VeriChip Amended IPO Filing and Backdoor Plays

Monday’s Top Biotech and Medical Stocks

Biotech Indices Mixed as AMEX Gains, Nasdaq Slips

Cramer’s Scientific Instrument Purchase for Tomorrow Morning

Cramer’s Biotech Pick Ahead of the J.P. Morgan Biotech Conference

FDA Fast Tracks Stem Cells for Crohn’s Disease

Friday’s Top Biotech and Medical Stocks

IBD Weekly Top Ranked Medical Stocks

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not